Literature DB >> 1930745

Sister chromatid exchange in patients treated with nonsteroidal anti-inflammatory drugs.

S Sardaş1, A E Karakaya, N Uğur, M Cengel, A Metin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1930745     DOI: 10.2165/00002018-199106050-00009

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  8 in total

1.  Increased frequency of sister chromatid exchanges in the peripheral lymphocytes of cigarette smokers.

Authors:  S Sardaş; S Gök; A E Karakaya
Journal:  Toxicol In Vitro       Date:  1991       Impact factor: 3.500

2.  [The effect of so-called basic therapeutics and symptomatically effective antirheumatic drugs on the enzymes of DNA synthesis and DNA repair].

Authors:  G Klein; A Wottawa
Journal:  Acta Med Austriaca       Date:  1975

3.  Investigations of the influence of nonsteroidal antirheumatic drugs on the rates of sister-chromatid exchange.

Authors:  W Kullich; G Klein
Journal:  Mutat Res       Date:  1986-06       Impact factor: 2.433

4.  Increased frequency of sister chromatid exchanges in cigarette smokers.

Authors:  B Lambert; A Lindblad; M Nordenskjöld; B Werelius
Journal:  Hereditas       Date:  1978       Impact factor: 3.271

5.  New Giemsa method for the differential staining of sister chromatids.

Authors:  P Perry; S Wolff
Journal:  Nature       Date:  1974-09-13       Impact factor: 49.962

Review 6.  Sister-chromatid exchanges: a report of the GENE-TOX program.

Authors:  S A Latt; J Allen; S E Bloom; A Carrano; E Falke; D Kram; E Schneider; R Schreck; R Tice; B Whitfield; S Wolff
Journal:  Mutat Res       Date:  1981-07       Impact factor: 2.433

7.  Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange.

Authors:  P Perry; H J Evans
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

Review 8.  Factors that influence formation of sister chromatid exchanges in human blood lymphocytes.

Authors:  B C Das
Journal:  Crit Rev Toxicol       Date:  1988       Impact factor: 5.635

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.